Physician profile
David Louis
NPI 1306294186
$4,723.50
in general payments reported to CMS, 2019-2025
8 companies · $1,278 in 2025
The $1,278 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $66.49 · 2021: $668 · 2022: $2,285 · 2023: $427 · 2025: $1,278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $888 · Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $887.51 |
| Food and Beverage | $816.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,897.70 | 2021-2025 | Onyx Frontier, Abre, Symplicity G3 |
| Boston Scientific Corporation | $1,314.66 | 2022 | |
| Abbott Laboratories | $502.51 | 2021-2022 | |
| Cardiovascular Systems INC. | $315.00 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $264.91 | 2020-2021 | |
| Inari Medical, INC. | $189.12 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $139.39 | 2021 | |
| Ge Healthcare | $100.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Louis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.